XML 60 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK-BASED COMPENSATION AND INCENTIVE PLANS (Tables)
9 Months Ended
Dec. 31, 2017
Schedule of Common Stock Shares Reserved for Issuance and Shares Available for Grant

The number of common stock shares reserved for issuance under the plans and the number of shares available for future grants are as follows:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Period from

 

 

 

Period from

 

 

 

 

 

 

 

August 1, 2017

 

 

 

April 1, 2017

 

 

 

 

 

 

 

through

 

 

 

through

 

 

Year Ended

 

 

 

December 31, 2017

 

 

 

July 31, 2017

 

 

March 31, 2017

 

Shares of common stock reserved for issuance under the plans

 

 

3,048,877

 

 

 

 

 

 

 

1,900,769

 

Shares of common stock available for future grants

 

 

1,891,231

 

 

 

 

 

 

 

505,221

 

 

Fair Value and Assumptions Used for Stock Options Issued

The fair value and assumptions used for the stock options issued during the years ended March 31, 2016 and 2015 are as follows:

 

 

 

2016

 

 

2015

 

Weighted average fair value of stock options granted

 

$

3.34

 

 

$

5.54

 

Risk-free interest rate

 

 

1.62

%

 

 

1.82

%

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

Expected stock price volatility

 

 

45

%

 

 

30

%

Expected stock option life

 

6.5 years

 

 

6.5 years

 

 

Schedule of Stock Option Activity

The following table sets forth a summary of stock option activity of the company:

 

 

 

Weighted-average

Exercise Price

 

 

Number of

Shares

 

Outstanding at March 31, 2016 (Predecessor)

 

$

31.73

 

 

 

1,777,124

 

Granted

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

Expired or cancelled/forfeited

 

 

44.86

 

 

 

(381,576

)

Outstanding at March 31, 2017 (Predecessor)

 

 

28.14

 

 

 

1,395,548

 

Granted

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

Expired or cancelled/forfeited

 

 

28.14

 

 

 

(1,395,548

)

Outstanding at July 31, 2017 (Predecessor)

 

 

 

 

 

 

Granted

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

Expired or cancelled/forfeited

 

 

 

 

 

 

Outstanding at December 31, 2017 (Successor)

 

$

 

 

 

 

 

Additional Information Regarding Stock Options

Additional information regarding stock options is as follows:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Period from

 

 

 

Period from

 

 

 

 

 

 

 

August 1, 2017

 

 

 

April 1, 2017

 

 

 

 

 

 

 

through

 

 

 

through

 

 

Year Ended

 

(In thousands, except number of stock options and weighted average price)

 

December 31, 2017

 

 

 

July 31, 2017

 

 

March 31, 2017

 

Intrinsic value of options exercised

 

 

 

 

 

 

 

 

 

 

Number of stock options vested

 

 

 

 

 

 

 

 

 

266,311

 

Fair value of stock options vested

 

$

 

 

 

 

 

 

 

1,185

 

Number of options exercisable

 

 

 

 

 

 

 

 

 

999,849

 

Weighted average exercise price of options exercisable

 

$

 

 

 

 

 

 

 

34.36

 

 

Effect on Basic and Diluted Earnings Per Share, and Stock Option Compensation Expense

Stock option compensation expense along with the reduction effect on basic and diluted earnings per share are as follows:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Period from

 

 

 

Period from

 

 

 

 

 

 

 

August 1, 2017

 

 

 

April 1, 2017

 

 

 

 

 

 

 

through

 

 

 

through

 

 

Year Ended

 

(In thousands, except per share data)

 

December 31, 2017

 

 

 

July 31, 2017

 

 

March 31, 2017

 

Stock option compensation expense

 

$

 

 

 

 

1,644

 

 

 

745

 

Basic loss per share increased by

 

 

 

 

 

 

0.02

 

 

 

0.02

 

Diluted loss per share increased by

 

 

 

 

 

 

0.02

 

 

 

0.02

 

 

Summary of Cash-Based Performance Plan Unit Activity

The following table sets forth a summary of cash-based performance plan unit activity of the company:

 

 

 

Weighted-average

Grant-Date

Fair Value

 

 

Performance

Based

Units

 

Non-vested balance at March 31, 2016 (Predecessor)

 

$

1.16

 

 

 

7,913,716

 

Granted

 

 

 

 

 

 

Vested

 

 

 

 

 

 

Cancelled/forfeited

 

 

1.15

 

 

 

(179,991

)

Non-vested balance at March 31, 2017 (Predecessor)

 

 

1.16

 

 

 

7,733,725

 

Granted

 

 

 

 

 

 

Vested

 

 

 

 

 

 

Cancelled/forfeited

 

 

1.16

 

 

 

(7,733,725

)

Non-vested balance at July 31, 2017 (Predecessor)

 

 

 

 

 

 

 

Summary of Deferred Stock Unit Activity

The following table sets forth a summary of deferred stock unit activity of the company:

 

 

 

Weighted-average

Grant-Date

Fair Value

 

 

Number

Of

Units

 

Balance at March 31, 2016 (Predecessor)

 

$

23.58

 

 

 

363,630

 

Dividend equivalents reinvested

 

 

 

 

 

 

Retirement distribution

 

 

6.83

 

 

 

(12,792

)

Granted

 

 

 

 

 

 

Balance at March 31, 2017 (Predecessor)

 

 

24.19

 

 

 

350,838

 

Dividend equivalents reinvested

 

 

 

 

 

 

Retirement distribution

 

 

24.19

 

 

 

(350,838

)

Granted

 

 

 

 

 

 

Balance at July 31, 2017 (Predecessor)

 

 

 

 

 

 

 

Schedule of Deferred Cash Award Expense

Deferred cash award expense, which is reflected in general and administrative expenses, is as follows:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Period from

 

 

 

Period from

 

 

 

 

 

 

 

August 1, 2017

 

 

 

April 1, 2017

 

 

 

 

 

 

 

through

 

 

 

through

 

 

Year Ended

 

(In thousands)

 

December 31, 2017

 

 

 

July 31, 2017

 

 

March 31, 2017

 

Deferred cash award expense

 

$

 

 

 

 

12

 

 

 

978

 

 

Deferred Stock Unit  
Schedule of Restricted Stock Compensation Expense and Grant Date Fair Value

Deferred stock unit compensation expense, which is reflected in general and administrative expenses, is as follows:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Period from

 

 

 

Period from

 

 

 

 

 

 

 

August 1, 2017

 

 

 

April 1, 2017

 

 

 

 

 

 

 

through

 

 

 

through

 

 

Year Ended

 

(In thousands)

 

December 31, 2017

 

 

 

July 31, 2017

 

 

March 31, 2017

 

Deferred stock units compensation expense (benefit)

 

$

 

 

 

 

(68

)

 

 

(1,987

)

 

Restricted Stock Units (RSUs)  
Summary Of Restricted Stock Unit Activity

The following table sets forth a summary of restricted stock unit activity of the company:

 

 

 

Weighted-average

Grant-Date

Fair Value

 

 

Time

Based

Units

 

 

Weight-average

Grant Date

Fair Value

 

 

Performance

Based Units

 

Non-vested balance at March 31, 2016 (Predecessor)

 

$

49.17

 

 

 

89,639

 

 

 

61.75

 

 

 

156,851

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Vested

 

 

49.39

 

 

 

(76,006

)

 

 

 

 

 

 

Cancelled/forfeited

 

 

49.62

 

 

 

(13,450

)

 

 

61.75

 

 

 

(156,851

)

Non-vested balance at March 31, 2017 (Predecessor)

 

 

54.48

 

 

 

183

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Vested

 

 

54.48

 

 

 

(183

)

 

 

 

 

 

 

Cancelled/forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Non-vested balance at July 31, 2017 (Predecessor)

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

24.40

 

 

 

1,203,379

 

 

 

 

 

 

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

24.15

 

 

 

(45,733

)

 

 

 

 

 

 

Non-vested balance at December 31, 2017 (Successor)

 

$

24.41

 

 

 

1,157,646

 

 

 

 

 

 

 

 

Schedule of Restricted Stock Compensation Expense and Grant Date Fair Value

Restricted stock unit compensation expense and grant date fair value are as follows:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Period from

 

 

 

Period from

 

 

 

 

 

 

 

August 1, 2017

 

 

 

April 1, 2017

 

 

 

 

 

 

 

through

 

 

 

through

 

 

Year Ended

 

(In thousands)

 

December 31, 2017

 

 

 

July 31, 2017

 

 

March 31, 2017

 

Grant date fair value of restricted stock units vested

 

$

 

 

 

 

10

 

 

 

3,754

 

Restricted stock unit compensation expense

 

 

3,731

 

 

 

 

2

 

 

 

2,425

 

 

Phantom Stock Plan  
Schedule of Restricted Stock Compensation Expense and Grant Date Fair Value

Phantom stock compensation expense and grant date fair value of phantom stock vested are as follows:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Period from

 

 

 

Period from

 

 

 

 

 

 

 

August 1, 2017

 

 

 

April 1, 2017

 

 

 

 

 

 

 

through

 

 

 

through

 

 

Year Ended

 

(In thousands)

 

December 31, 2017

 

 

 

July 31, 2017

 

 

March 31, 2017

 

Grant date fair value of phantom stock vested

$

 

 

 

 

 

 

 

 

7,118

 

Phantom stock compensation expense

 

 

94

 

 

 

 

68

 

 

 

467

 

 

Summary of Phantom Stock Activity

The following table sets forth a summary of phantom stock activity of the company:

 

 

 

Weighted-average

Grant-Date

Fair Value

 

 

Time

Based

Shares

 

 

Weighted-average

Grant-Date

Fair Value

 

 

Series A Warrants

 

 

Weighted-average

Grant-Date

Fair Value

 

 

Series B Warrants

 

Non-vested balance at March 31, 2016 (Predecessor)

 

$

10.83

 

 

 

1,599,829

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested

 

 

12.29

 

 

 

(585,426

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

13.52

 

 

 

(68,253

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-vested balance at March 31, 2017 (Predecessor)

 

 

9.74

 

 

 

946,150

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

'Cancelled (A)

 

 

9.70

 

 

 

(484,446

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

10.08

 

 

 

(16,866

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-vested balance at July 31, 2017 (Predecessor) (B)

 

 

9.77

 

 

 

444,838

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of Successor phantom stock (B)

 

 

308.19

 

 

 

14,160

 

 

 

1.00

 

 

 

22,963

 

 

 

0.98

 

 

 

24,824

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at August 1, 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

307.31

 

 

 

(634

)

 

 

1.00

 

 

 

(1,029

)

 

 

0.98

 

 

 

(1,112

)

Non-vested balance at December 31, 2017 (Successor)

 

$

308.24

 

 

 

13,526

 

 

 

1.00

 

 

 

21,934

 

 

 

0.98

 

 

 

23,712

 

 

 

(A)

Prior to emergence from Chapter 11 bankruptcy, all officer-held phantom stock units were cancelled. Refer to Item 7. “Reorganization and Chapter 11 Proceedings.”

 

 

(B)

Upon emergence from Chapter 11 bankruptcy, all outstanding phantom stock units held by non-officer employees were converted by the same conversion ratio applied to the common shares upon emergence. Every 31.4143 phantom stock units converted into one phantom stock unit post emergence which is valued to the new common stock. In addition, each post emergence phantom stock unit received 1.6216 phantom series A warrants and 1.7531 phantom series B warrants. Both warrant series have time-based vesting and follow the vesting schedule of the underlying phantom stock unit. Refer to Item 7. “Reorganization and Chapter 11 Proceedings.”

Cash-based Performance Plan  
Schedule of Restricted Stock Compensation Expense and Grant Date Fair Value

Cash-based performance unit compensation expense and grant date fair value are as follows:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Period from

 

 

 

Period from

 

 

 

 

 

 

 

August 1, 2017

 

 

 

April 1, 2017

 

 

 

 

 

 

 

through

 

 

 

through

 

 

Year Ended

 

(In thousands)

 

December 31, 2017

 

 

 

July 31, 2017

 

 

March 31, 2017

 

Grant date fair value of cash-based performance units vested

 

$

 

 

 

 

 

 

 

 

Cash-based performance unit compensation expense

 

 

 

 

 

 

(1,975

)

 

 

761